Search For "krishna ella"
Updated : 1 week, 2 days ago IST
New Delhi [India], November 24 (ANI): The development of the country's indigenous COVID-19 vaccine Covaxin is a true success story for public-private partnerships in India, which is based on mutual respect, trust and transparency, said Dr Krishna Ella, Chairman and Managing Director, Bharat
Updated : 3 weeks ago IST
Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.
Updated : 3 weeks, 1 day ago IST
New Delhi [India], November 11 (ANI): People will need booster doses of the COVID-19 vaccine if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella.
Updated : 4 weeks, 1 day ago IST
New Delhi [India], November 3 (ANI): After Bharat Biotech's Covaxin, was granted Emergency Use Listing (EUL) by the World Health Organization (WHO) on Wednesday, Dr. Krishna Ella, chairman and MD of the Hyderabad-based vaccine manufacturer said the validation was a "momentous occasion for In
Updated : 1 month, 1 week ago IST
New Delhi [India], October 23(ANI): Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the COVID-19 vaccine for children.
Hyderabad (Telangana) [India], October 22 (ANI): As India on Thursday achieved the milestone of administering 100 crore COVID-19 vaccine doses so far, Chairman and Managing Director of Bharat Biotech Dr Krishna Ella lauded the government's system for this achievement.
New Delhi [India], October 21 (ANI): As India on Thursday crossed 100 crore COVID-19 vaccination, Bharat Biotech's Chairman and Managing Director Dr Krishna Ella said that the firm is proud to have contributed to this 'historic landmark'.
Updated : 3 months, 3 weeks ago IST
Hyderabad (Telangana) [India], August 13 (ANI): In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get vaccinated at the earliest, the Central Government requested that Indian Immunologicals Limited (IIL) and Bha
Updated : 5 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Updated : 11 months ago IST
New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's indigenously developed coronavirus vaccine COVAXIN, the Hyderabad-based biotech major's managing director Dr Krishna Ella on Monday slammed the critics for targeting Indian clinica
Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr
Hyderabad (Telangana) [India], January 4 (ANI): Covaxin, the indigenous vaccine developed by Bharat Biotech against COVID-19 in collaboration with ICMR, is 200 per cent safe, company's Chairman and Managing Director Dr Krishna Ella has said and noted that it has shown less than 10 per cen